What one share of Alvotech holds
Alvotech makes biosimilar medicines, which are lower-cost copies of proven biological treatments, and sells them to patients around the world. The company handles both developing and manufacturing these medicines itself, aiming to make treatments for a range of diseases more widely available.
Alvotech’s numbers from its SEC filings, divided by its shares. Results cover the latest fiscal year to 2025-12-31; the balance sheet is as of 2025-12-31.
| Sales | $2.01 |
|---|---|
| Profit | $0.10 |
| Capex (buildings and equipment) | $0.22 |
| Free cash flow | −$0.39 |
| Dividends | $0.00 |
| Cash and investments | $0.55 |
| Debt | $4.16 |
| Book value | −$0.91 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2020 | $0.71 | −$1.82 | $0.08 | −$0.87 | — | −$9.26 |
| 2021 | $0.33 | −$0.92 | $0.18 | −$2.25 | — | — |
| 2022 | $0.42 | −$2.60 | $0.19 | −$1.77 | — | −$2.24 |
| 2023 | $0.40 | −$2.43 | $0.15 | −$1.52 | — | −$3.49 |
| 2024 | $1.83 | −$0.87 | $0.20 | −$1.08 | — | −$1.37 |
| 2025 | $2.01 | $0.10 | $0.22 | −$0.39 | — | −$0.91 |
Common questions about Alvotech
How much does one share of Alvotech earn?
Over its latest fiscal year, each share of Alvotech earned $0.10 of profit on $2.01 of sales, keeping about 5¢ of every $1 (profit margin).
Does Alvotech pay a dividend?
Alvotech didn’t pay a dividend over its latest fiscal year, according to its SEC filings.
What is Alvotech’s book value per share?
Alvotech’s book value is negative (−$0.91 per share): it owes more than everything it owns is recorded at, often after years of buying back its own shares, as of December 31, 2025.
How much cash and debt does each share of Alvotech have?
Each share of Alvotech has $0.55 of cash and investments and $4.16 of debt, as of December 31, 2025.
What is Alvotech’s free cash flow per share?
−$0.39 per share over its latest fiscal year. Free cash flow is the cash left over after spending on buildings and equipment.
Has Alvotech bought back shares?
Alvotech’s share count rose about 211% from 2020 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.